National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

计划入组 1,000 人 · 首次发布于 2024 年 7 月 9 日

Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer

计划入组 150 人 · 首次发布于 2017 年 5 月 25 日

Elemene Liposomes in Endometrial Cancer

计划入组 212 人 · 首次发布于 2026 年 7 月 31 日

EG Myocin (EyeGene)

EG Myocin(EyeGene, Inc.)

EG-Vac

EyeGene, Inc.

South Korea

EYEGENE Inc.

South Korea

enGene

Canada

Korea University-Moderna mRNA Hantavirus Vaccine Stalls as Funding Shortfall Blocks Clinical Trials

Syngene International Extends Strategic Bristol Myers Squibb Collaboration Through 2035

Syngene International's Bengaluru Facility Receives Clean FDA Inspection with NAI Status